120 related articles for article (PubMed ID: 12512025)
1. The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans.
Sarkar S; Hobson AR; Hughes A; Growcott J; Woolf CJ; Thompson DG; Aziz Q
Gastroenterology; 2003 Jan; 124(1):18-25. PubMed ID: 12512025
[TBL] [Abstract][Full Text] [Related]
2. Patients with chest pain and occult gastroesophageal reflux demonstrate visceral pain hypersensitivity which may be partially responsive to acid suppression.
Sarkar S; Thompson DG; Woolf CJ; Hobson AR; Millane T; Aziz Q
Am J Gastroenterol; 2004 Oct; 99(10):1998-2006. PubMed ID: 15447763
[TBL] [Abstract][Full Text] [Related]
3. Constitutive cyclo-oxygenase-2 does not contribute to the development of human visceral pain hypersensitivity.
Willert RP; Delaney C; Hobson AR; Thompson DG; Woolf CJ; Aziz Q
Eur J Pain; 2006 Aug; 10(6):487-94. PubMed ID: 16122956
[TBL] [Abstract][Full Text] [Related]
4. The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor.
Willert RP; Woolf CJ; Hobson AR; Delaney C; Thompson DG; Aziz Q
Gastroenterology; 2004 Mar; 126(3):683-92. PubMed ID: 14988822
[TBL] [Abstract][Full Text] [Related]
5. Development of esophageal hypersensitivity following experimental duodenal acidification.
Hobson AR; Khan RW; Sarkar S; Furlong PL; Aziz Q
Am J Gastroenterol; 2004 May; 99(5):813-20. PubMed ID: 15128342
[TBL] [Abstract][Full Text] [Related]
6. Gastric hypersensitivity induced by oesophageal acid infusion in healthy volunteers.
van den Elzen BD; Tytgat GN; Boeckxstaens GE
Neurogastroenterol Motil; 2009 Feb; 21(2):160-9. PubMed ID: 18713312
[TBL] [Abstract][Full Text] [Related]
7. Analgesic efficacy of peripheral kappa-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain.
Arendt-Nielsen L; Olesen AE; Staahl C; Menzaghi F; Kell S; Wong GY; Drewes AM
Anesthesiology; 2009 Sep; 111(3):616-24. PubMed ID: 19672186
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E(2) mediates acid-induced heartburn in healthy volunteers.
Kondo T; Oshima T; Tomita T; Fukui H; Watari J; Okada H; Kikuchi S; Sasako M; Matsumoto T; Knowles CH; Miwa H
Am J Physiol Gastrointest Liver Physiol; 2013 Mar; 304(6):G568-73. PubMed ID: 23370674
[TBL] [Abstract][Full Text] [Related]
9. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM
Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468
[TBL] [Abstract][Full Text] [Related]
10. Central pain mechanisms following combined acid and capsaicin perfusion of the human oesophagus.
Brock C; Andresen T; Frøkjaer JB; Gale J; Olesen AE; Arendt-Nielsen L; Drewes AM
Eur J Pain; 2010 Mar; 14(3):273-81. PubMed ID: 19541517
[TBL] [Abstract][Full Text] [Related]
11. Adenosine modulates oesophageal sensorimotor function in humans.
Remes-Troche JM; Chahal P; Mudipalli R; Rao SS
Gut; 2009 Aug; 58(8):1049-55. PubMed ID: 18285398
[TBL] [Abstract][Full Text] [Related]
12. Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers.
Kraft B; Frickey NA; Kaufmann RM; Reif M; Frey R; Gustorff B; Kress HG
Anesthesiology; 2008 Jul; 109(1):101-10. PubMed ID: 18580179
[TBL] [Abstract][Full Text] [Related]
13. Modulation of esophageal afferent pathways by 5-HT3 receptor inhibition.
Szczesniak MM; Fuentealba SE; Zhang T; Cook IJ
Neurogastroenterol Motil; 2013 May; 25(5):383-8, e293. PubMed ID: 23360084
[TBL] [Abstract][Full Text] [Related]
14. Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity.
Rodriguez-Stanley S; Zubaidi S; Proskin HM; Kralstein JR; Shetzline MA; Miner PB
Clin Gastroenterol Hepatol; 2006 Apr; 4(4):442-50. PubMed ID: 16616348
[TBL] [Abstract][Full Text] [Related]
15. Contribution of central sensitisation to the development of non-cardiac chest pain.
Sarkar S; Aziz Q; Woolf CJ; Hobson AR; Thompson DG
Lancet; 2000 Sep; 356(9236):1154-9. PubMed ID: 11030295
[TBL] [Abstract][Full Text] [Related]
16. Effects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett's esophagus.
Piazuelo E; Jiménez P; Strunk M; Santander S; García A; Esteva F; Lanas A
Prostaglandins Other Lipid Mediat; 2006 Dec; 81(3-4):150-61. PubMed ID: 17085323
[TBL] [Abstract][Full Text] [Related]
17. The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats.
Winston J; Shenoy M; Medley D; Naniwadekar A; Pasricha PJ
Gastroenterology; 2007 Feb; 132(2):615-27. PubMed ID: 17258716
[TBL] [Abstract][Full Text] [Related]
18. Evoked human oesophageal hyperalgesia: a potential tool for analgesic evaluation?
Olesen AE; Staahl C; Brock C; Arendt-Nielsen L; Drewes AM
Basic Clin Pharmacol Toxicol; 2009 Aug; 105(2):126-36. PubMed ID: 19422357
[TBL] [Abstract][Full Text] [Related]
19. Evidence for oesophageal visceral hypersensitivity and aberrant symptom referral in patients with globus.
Chen CL; Szczesniak MM; Cook IJ
Neurogastroenterol Motil; 2009 Nov; 21(11):1142-e96. PubMed ID: 19422528
[TBL] [Abstract][Full Text] [Related]
20. Role of periaqueductal grey prostaglandin receptors in formalin-induced hyperalgesia.
Oliva P; Berrino L; de Novellis V; Palazzo E; Marabese I; Siniscalco D; Scafuro M; Mariani L; Rossi F; Maione S
Eur J Pharmacol; 2006 Jan; 530(1-2):40-7. PubMed ID: 16360148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
